Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2025 10:22 ET | Source: Pomerantz LLP

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) and certain...
June 05, 2025 08:30 ET | Source: AstuteAnalytica India Pvt. Ltd.

United States Clinical Laboratory Services Market is Poised to Reach Valuation of US$ 144.3 Billion By 2033 | Astute Analytica

Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The United States clinical laboratory services market was valued at US$ 99.7 billion in 2024 and is expected to reach US$ 144.3 billion by 2033, growing at...
May 06, 2025 05:21 ET | Source: Research and Markets

Global Cannabis-Infused Edibles Market Forecast Report 2025-2030: Detailed Forecast by Product Type, Flavor, and Consumer Trends

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Cannabis-infused Edibles Market by Product Types (Baked Goods, Beverages, Chocolates), Flavor (Fruity, Savory, Sweet), Ingredients, Gender, Distribution...
April 15, 2025 04:19 ET | Source: Research and Markets

U.S. Cannabis Market to Reach $76.39 Billion by 2030 Fueled by Legalization, Celebrity Branding, and Medical Adoption

Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cannabis Market Size, Share & Trends Analysis Report 2025-2030" has been added to ResearchAndMarkets.com's offering.The U.S. cannabis market...
April 09, 2025 19:03 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...
April 07, 2025 16:49 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, April 07, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...
April 04, 2025 11:18 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...
April 02, 2025 09:35 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...
March 31, 2025 19:25 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...
March 28, 2025 13:45 ET | Source: Hagens Berman Sobol Shapiro LLP

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on...